Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Cellebrite DI Ltd. market cap for the quarter ending 2026-02-23 was $2.98B, a 27.88% decline year-over-year.
Cellebrite DI Ltd. market cap for the quarter ending 2025-12-31 was $4.48B, a 13.23% decline year-over-year.
Cellebrite DI Ltd. market cap for the quarter ending 2025-06-30 was $3.91B, a 57.55% increase year-over-year.
Cellebrite DI Ltd. market cap for the quarter ending 2025-03-11 was $4.13B, a 75.53% increase year-over-year.
Cellebrite DI Ltd. market cap for fiscal 2026 was $2.98B.
Cellebrite DI Ltd. market cap for fiscal 2025 was $4.48B, a 13.23% decline from fiscal 2024.
Cellebrite DI Ltd. market cap for fiscal 2024 was $5.17B, a 193.56% increase from fiscal 2023.
Cellebrite DI Ltd. market cap for fiscal 2023 was $1.76B, a 109.14% increase from fiscal 2022.